Six months post fMCAo, we examined how the stroke altered the number of proliferating neuroblasts (positive for 5-bromo-2′-deoxyuridine and DCX (BrdU+/DCX+)) and differentiated astrocytes (positive for glial fibrillary acidic protein (GFAP+)) in the ipsilateral and contralateral neurogenic region of these mice—the subventricular zone. This evidence concerns the gene DCX and stroke disorder.